The European Bank for Reconstruction and Development (EBRD), alongside MidEuropa and other investors, is supporting, with an equity investment of €24 million, the acquisition in Greece of Famar, a leading pharmaceutical contract development and manufacturing organisation (CDMO).
The EBRD’s investment will support Famar’s ambitious growth plans, including the expansion of its production capacity and research and development (R&D) facilities in Greece.
Headquartered in Greece and with production sites in Greece, Italy and Spain, Famar is a leading pharmaceutical CDMO, focusing on the manufacturing and distribution of a wide range of pharmaceutical, consumer health and cosmetic products.
Under the new ownership, Famar plans to make substantial investments in Greece to expand both its R&D and sterile manufacturing capabilities, among others, as the company continues to shift its product mix towards higher-value-added products.
The EBRD started operating in Greece on a temporary basis in 2015 to support the country’s economic recovery. To date, the Bank has invested more than €7.9 billion in 115 projects in the corporate, financial, energy and infrastructure sectors of the Greek economy.
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=67162050e709493cbc18bc283dbf4c83&url=https%3A%2F%2Fwww.ebrd.com%2Fnews%2F2024%2Febrd-invests-24-million-in-famar-in-greece.html&c=9441234587016538449&mkt=de-de
Author :
Publish date : 2024-10-21 02:34:00
Copyright for syndicated content belongs to the linked Source.
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish